Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Knowing what to include in your retirement portfolio at 30 can set you up for success. Learn about essential assets and strategies.
20,742 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A private AI company is offering under-$1 pre-IPO shares to everyday investors as it targets a Nasdaq debut later thi...
Major indices surge as news of a potential Iran peace framework reduces geopolitical risk. Oil slides below $100, eas...
Kharg Island, a key Iran oil export hub, is under the spotlight as geopolitical tensions heighten risk to energy flow...
As confirmation hearings approach, kevin warsh’s undisclosed wealth becomes a flashpoint, with a 69-page filing leavi...
As Progyny gears up for 2026, investors want clarity on what drives progyny (pgny) 2026 earnings. This guide breaks d...
When Palantir reveals new AI-focused capabilities, Nvidia stock often faces a unique set of pressures. This guide bre...
A significant leadership reshuffle at a high-profile exclusive: ozempic prescription startup signals a broader pivot ...
Resideo Technologies stock slid after its quarterly update, underscoring how guidance and costs matter as the company...
This deep-dive breaks down accelerant (arx) 2026 earnings, translating the Q1 transcript into actionable takeaways. L...
In May 2026, additive manufacturing stocks are catching fresh interest as manufacturers push for faster production cy...
ATRenew (RERE) 2026 earnings in Q1 offer a clearer view of the company’s path forward. This guide breaks down what to...